drugset / Trial / NCT00042068
A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis
RandomizedParallel-groupDouble-blind
Summary
A 12-week trial consisting of 5 visits (6 if follow up is needed) to find out how effective and safe three different doses of meloxicam are compared with placebo in Rheumatoid Arthritis. Patient will take one dose of study medication daily.
Timeline
- Start
- 2002-06
- Primary completion
- —
- Completion
- 2003-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meloxicam | Small molecule | 7.5 mg | — |
| Subject | Meloxicam | Small molecule | 15 mg | — |
| Subject | Meloxicam | Small molecule | 22.5 mg | — |